Rapid Results in any DOA Scenario - New SURESTEP^® Drug Screen Tests Launched

According to the United Nations¹, some 200 million people, or 5 per cent of the global population, aged 15-64, have used illicit drugs at least once in the last 12 months. Inverness Medical has responded to growing demand for improved drugs of abuse testing by launching SureStep^® Drug Screen Tests. This versatile easy to use panel of qualitative tests detects a wide range of drugs of abuse, from ecstasy to cocaine.

SureStep Drug Screen Tests feature single and multiple panel tests, providing additional flexibility for targeted testing or the simultaneous detection of up to 9 drugs with a single sample. These can include TCA, amphetamine, MDMA (ecstasy), cocaine, morphine, THC (cannabis), barbiturates, methamphetamine, benzodiazepines and methadone. Utilising Inverness Medical’s pioneering and innovative lateral flow technology, SureStep Drug Screen Tests deliver rapid, accurate and reliable results in urine samples in as little as 5 minutes.

According to Inverness Medical’s VP International Business, David Walton, the simple, one-step tests with built-in procedural controls are designed for use in virtually any test setting – for example at the point of care in emergency rooms and rehabilitation clinics: “They also form a vital element in workplace assessments, occupational health screening and criminal justice systems. Some idea of the scale of the need for testing comes from the US Department of Health and Human Services figures, which estimate that of the 17.2 million current illicit drug users aged 18 or older in 2005, 12.9 million (74.8 percent) were employed either full or part time.” ²

SureStep Drug Screen Tests are available in 40 test kits (single panel) and 25 test kits (multiple panel) formats. They have a long shelf life, multi-lingual instruction leaflets and can be stored at room temperature.

References
1. United Nations Office on Drugs and Crime Drug Report 2007
2. 2005 National Survey on Drug Use and Health